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Abstract: Introduction: Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplasia of unknown 
etiology occurring in both children and adults. This condition is characterized by an abnormal proliferation of 
Langerhans cells that may virtually affect all sites in the human body. Oral manifestations of LCH could be the first 
clinical sign of disease and its periodontal localization could be easily mistaken for other more common entities, 
such as chronic periodontitis, aggressive periodontitis, and necrotizing ulcerative periodontitis. Case presentation: 
A 32-years old female visited a private dental practice with a chief complaint of sensitivity in the mandibular left first 
molar. Clinical and radiographic examination revealed deep periodontal pocket, recession, furcation involvement, 
mobility, severe alveolar bone destruction and a diagnosis of aggressive periodontitis was rendered. Multiple tooth 
extractions were carried out due to progressive periodontal destruction with impaired healing and development 
of ulcerative lesions. Multidisciplinary investigation demonstrated that the periodontal involvement was a 
manifestation of an underlying systemic disease. A biopsy of a bone lesion was therefore performed, revealing the 
presence of multifocal single system LCH. Conclusion: The identification of periodontal LCH is not trivial given that 
it may clinically resemble other periodontal disease entities. The dentist can be the first health care personnel to 
unravel the presence of an underlying systemic LCH. 
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Introduction 
Langerhans cell histiocytosis (LCH) is the most 
common histiocytic disorder, which is charac- 
terized by an abnormal proliferation of CD1a-
positive histiocytes, i.e. Langerhans cells [1]. 
This exceedingly rare inflammatory myeloid 
neoplasia may affect virtually all organ systems 
of the human body, with no predilection of gen-
der [1, 2]. Despite affecting any age group, from 
newborns to elders, the incidence of LCH is 
higher in children compared to adults, with a 
median age of presentation of 30 months [3]. 
In particular, young Caucasian individuals are 
reported to be the highest-risk population [4]. 
Although the etiology of LCH remains enigmat-
ic, possible causative factors have been pro-
posed, including disturbance in immunoregula-
tion, genetic factors, thyroid diseases and 
smoking [5-8]. The biology underpinning LCH is 
still a subject of debate; however, recent ad- 
vances in the genomic characterization of this 
rare condition revealed the presence of an acti-
vating hotspot V600E somatic mutation in the 
proto-oncogene B-Raf (BRAF) in up to 57% of 
cases [9]. Moreover, activation of extracellular-
signal-regulated kinases (ERKs) appeared to be 
universal in LCH in recent molecular studies 
[10].
The clinical course of LCH is highly variable and 
unpredictable, existing along a spectrum of dis-
ease that may involve a single site (unifocal), 
multiple sites (multifocal) in a single organ sys-
tem or multiple organ systems (multisystem) 
which could affect a limited number of organs 
or either be disseminated and life threatening 
[2, 11]. Bone is the most commonly involved tis-
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sue [12] with the skull being the most frequent 
site (55%), followed by vertebrae (30%) and 
jaws (26%) [13].
Oral manifestations could be the first sign of 
LCH, being reported in up to 20% of cases as 
the initial clinical event [14]. This condition may 
precede evidence of systemic disease, giving 
rise to nonspecific symptoms and generally 
prompts patients to seek dental treatment [6]. 
In this scenario, the role of the dentist is criti-
cal, particularly for cases in which the oral cav-
ity is the only involved area [15]. Alveolar and 
basal bone lesions are common findings in oral 
LCH, with increased frequency in the molar 
region of the jaw [7]. Severe and progressive 
destruction of the alveolar bone gives rise to 
the characteristic radiographic appearance of 
floating teeth [6]. When periodontal tissues are 
involved, the gingival margin is typically ery-
thematous and hyperplastic with evident ulcer-
ation of interdental papillae [16]. Bleeding, re- 
cession, ulceration, necrosis, and tooth hyper- 
mobility are common although nonspecific find-
ings, since they may mimic other diseases of 
the periodontal region including chronic peri-
odontitis, aggressive periodontitis, and necro-
tizing ulcerative periodontitis [15]. As a result, 
tooth exfoliation is a common finding. If teeth 
are extracted due to loosening and excessive 
mobility, delayed healing of the extraction sites 
occurs and could be suggestive for the pres-
ence of LCH [16]. 
Once biopsy is performed, diagnosis of LCH is 
straightforward, since the presence of an 
abnormal proliferation of CD1a-positive, S100-
positive histiocytes with an inflammatory back- 
ground, including variable numbers of lympho- 
cytes (enriched for regulatory T cells), macro- 
phages and eosinophils is pathognomonic [7, 
16]. However, a multidisciplinary approach is 
essential to disclose any systemic involvement, 
since a correct patient’s management is based 
on the integration of clinical, histological, radio- 
graphic, laboratory and molecular data [16].
The present case epitomizes the clinical situa-
tion of a single system LCH mimicking aggres-
sive periodontitis in a patient with no other 
clinical signs. Although this is a single observa-
tion, we highlight the importance of a multidis-
ciplinary approach in such rare conditions for a 
fruitful patient management. 
Figure 1. The site of chief complaint in the 
mandibular left first molar: A. Close-up 
view of the lingual side revealing inflam-
mation and severe gingival recession. 
B. Periapical radiograph portraying a se-
vere alveolar bone resorption (arrows). C. 
Panoramic radiograph revealing localized 
bone resorption at the site of chief com-
plaint (arrow).
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Case report
A 32-year old Caucasian female visited a pri-
vate dental practice in Brescia, Italy for a chief 
complaint of sensitivity in the mandibular left 
first molar. Medical history disclosed chronic 
hormone replacement therapy (HRT) due to 
gonadal dysgenesis. Intra-oral examination 
revealed edema and inflammation at the site of 
chief complaint, in the presence of severe gin-
gival recession on the lingual side (10 mm), 
deep periodontal pocket (maximum depths: 10 
mm buccally, 9 mm in lingually) grade 3 furca-
tion involvement and grade 2 tooth mobility 
(Figure 1A). Gingival and plaque indexes were 
both 2. Intra-oral periapical and panoramic 
radiographs demonstrated a well-defined non-
corticated radiolucent solitary lesion involving 
the mandibular left first and second molars. No 
signs of root resorption were evident (Figure 1B 
and 1C). Based on these findings, a diagnosis 
of periodontal lesion suggestive for aggressive 
periodontitis was rendered. 
Scaling and root planing were performed in 
multiple appointments. Oral hygiene instruc- 
tions were given and chlorhexidine mouthwash 
(0.2%) was recommended for daily use (3 
times/day for 10 days). Two months later, al- 
though soft tissue edema remarkably reduced, 
the mandibular left first molar was extracted 
due to symptomatic mobility and persistent 
root sensitivity. One month after extraction, 
soft tissues at the edentulous site were severe-
ly inflamed with delayed healing. Amoxicillin 
and clavulanic acid (875+125 mg, every 12 
hours for 10 days), metronidazole (250 mg, 
every 8 hours for 10 days) and chlorhexidine 
mouthwash were therefore prescribed. Endo- 
sseous implant placement was planned and 
consultation for bone grafting procedures was 
scheduled with the oral maxillofacial surgeon, 
since the site of extraction lacked sufficient 
bone support. Based on the surgeon’s assess-
ment, the patient was not a candidate for bone 
grafting procedures due to impaired healing of 
soft tissues. At this point, the patient failed to 
show up for successive follow-up appointments 
for undisclosed reasons. 
One year later, the patient attended the clinic 
complaining of symptoms in the mandibular 
right first molar. Intra-oral examination revealed 
severe gingival inflammation, excessive mobili-
ty and advanced alveolar bone destruction 
which was confirmed by radiographic analyses. 
Manual debridement was therefore performed 
and the same regimens of antibiotics and 
mouthwash were prescribed. After one month, 
the tooth was pulled out, given that the overall 
clinical conditions failed to show any impro- 
vement. Ulceration, fistulization and delayed 
soft tissue healing were noticeable few months 
after the extraction. Scaling was therefore per-
formed and, a month later, the area of the man-
dibular right first molar was re-opened, scraped-
out, debrided, and sutured. Periodontal asse- 
ssment revealed increasing pocket depth on 
the distal site of the maxillary right first molar; 
manual debridement and oral hygiene instruc-
tions were provided within the next few months; 
however, multiple extractions were executed 
due to severe periodontal destruction. One 
year later, an ulcerative lesion was present in 
the area palatal to the right maxillary first molar 
(Figure 2). Panoramic radiograph revealed 
severe alveolar bone destruction with “floating 
teeth” appearance and an osteolytic bone 
lesion at the left angle of the mandible (Figure 
3). With the deterioration of the overall clinical 
Figure 2. Close-up view of the soft tissue ulceration 
in the area palatal to the extracted maxillary right 
first molar.
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status and suspecting the presence of an 
underlying malignant condition, the patient was 
referred for deep analyses.
No abnormalities were observed in the labora-
tory and biochemical tests, while skull and 
sinus radiography displayed an oval radiolucen-
cy of 5 mm in size at the left angle of the man-
dible. Surprisingly, radiograph of the lower leg 
revealed multiple osteolytic bone lesions of the 
left tibia (Figure 4A). To define the nature of 
these lesions, bone-marrow aspiration and 
biopsy were performed. Histopathologic exami-
nation revealed a dense nodular proliferation 
of CD1a- and S100-positive Langerhans cells 
within bone in the background of a lymphocytic 
and granulocytic population consistent with 
LCH (Figure 4B-D). An additional biopsy was 
subsequently performed in order to determine 
the nature of the intra-oral lesion, showing 
mature disease-free compact bone. 
The patient started radiotherapy and therefore 
possible improvement of the oral and periodon-
tal condition is yet to be confirmed. At this point 
of time, bidirectional Sanger sequencing analy-
sis and pyrosequencing of DNA extracted from 
bone tissue of the tibia detected the presence 
of the BRAF V600E hotspot somatic mutation, 
confirming the clonal origin of the neoplastic 
cells.
Discussion
LCH is an exceedingly rare dendritic cell disor-
der with variable clinical courses that is cur-
ings [11]. Periodontal manifestations were simi-
lar to those that can be observed in severe peri-
odontal diseases, namely the presence of deep 
periodontal pockets, recession, furcation invol- 
vement, gingival bleeding and mobility [15]. 
This similarity, together with the rarity of this 
condition, resulted in an initial incorrect diagno-
sis. In fact, dentists and periodontists might 
lack familiarity with the exceptionally rare oral 
manifestations of LCH. Impaired soft tissue 
healing after extraction can be suggestive of 
LCH; however, multidisciplinary approaches are 
warranted. Furthermore, the lack of patient 
compliance in attending the scheduled appoint-
ments over a long period of time resulted in a 
deficient case monitoring that could have pro-
vided meaning for a biopsy much earlier. 
Correct diagnosis at early stages is crucial in 
preventing progressive destruction, inevitable 
tooth loss and reduces the chances of negative 
sequelae. For this patient, histopathological 
findings of bone marrow biopsy from the tibia 
showed an atypical proliferation of CD1a-
positive Langerhans cells which made the diag-
nosis of LCH trivial. However, the bioptic speci-
men from the mandibular bone underlying the 
area of extracted right third molar was incon-
clusive. This can be explained by the fact that a 
bone biopsy may be not representative of the 
entire lesion, particularly in cases of intraoral 
localization of LCH. When LCH is in question, a 
sufficient gingival biopsy should also be ob- 
tained, regardless tooth extraction [19]. At the 
molecular level, bone lesion of the left tibia har-
bored the recurrent V600E BRAF missense 
Figure 3. Panoramic radiograph showing the aggressive nature of the LCH. 
Severe bone destruction and the characteristic floating teeth appearance 
are evident (arrows), while a radiolucent lesion can be seen at the left angle 
of the mandible (star). This analysis was performed three years after the 
initial examination.
rently depicted as an inflam-
matory myeloid neoplasia [10]. 
LCH occurs less commonly in 
adults compared to the chil-
dren, with an incidence of 1-2 
adult individuals per million 
with an age range between 29 
and 38 years [3, 17]. Manifes- 
tations in the oral cavity can be 
the first and even the only sign 
of LCH, often resulting in peri-
odontal involvement [6, 15, 
18]. 
In the present case, the patient 
was affected by multifocal sin-
gle system LCH based on clini-
cal, radiographic, histologic, 
ancillary and molecular find-
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mutation, providing strong circumstantial evi-
dence that the association of LCH and BRAF 
somatic mutations is more than purely coinci- 
dental.
Improvement in controlling the oral manifesta-
tions of LCH can be successfully achieved with 
conventional and surgical periodontal treat-
ments, as reported by Klein and colleagues 
[20]. This could result in a substantial improve-
ment of the clinical condition of patients with 
oral LCH and suggest the opportunity of stabi-
lizing the periodontal conditions using standard 
procedures. In another case report [21], a 
27-year old male with recurrent LCH and severe 
periodontal manifestations underwent compre-
hensive periodontal therapy and prosthetic 
rehabilitation. In this case, the periodontal con-
dition remained stable for two years. Such find-
ings indicate that a regular follow-up is crucial 
in controlling the periodontal manifestations of 
LCH. Nonetheless, only local treatment of the 
various manifestations of LCH may be not suf-
ficient, as the presence of a related systemic 
condition must not be excluded. For this, a wide 
spectrum of systemic therapies are available, 
including chemotherapy, radiotherapy and cor-
ticosteroids [22]. 
The elective treatment of solitary bone lesions 
in the jaws is widely reported to be the surgical 
curettage. However, if the site is inaccessible to 
surgery then radiotherapy or chemotherapy are 
recommended [23]. Our patient has recently 
started radiotherapy and appointments have 
been scheduled for regular treatment and 
follow-up at the dental clinic. Therefore, an 
overall improvement of the condition cannot 
yet be determined. 
In the present case, LCH passed unrecognized 
over the course of few years. Unfortunately, 
periodontal disease progressed rapidly, leading 
to the loss of most of the dentition. Delayed 
healing of soft tissues post-extraction was per-
sistent. A close monitoring of the oral manifes-
tations of disease could have allowed an early 
Figure 4. Left tibial localizations of multifocal system-
ic LCH in a patient with periodontal manifestation of 
disease. X-ray analysis (A) identified the presence 
of multiple radiolucent oval lesions of various size, 
with regular and sharp borders. The histologic exami-
nation confirmed the pathologic nature of these le-
sions, revealing the presence of abnormal nodular 
proliferation of histiocytes within the bone marrow 
with an inflammatory background (B) (hematoxylin 
and eosin, original magnification 10×). This histiocyt-
ic population displayed CD1a-positive (C) and S100-
positive phenotype (D) at the immunohistochemical 
analysis (original magnification 20×).
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diagnosis of LCH, preventing the rapid deterio-
ration of the clinical conditions and possibly 
resulting in a better end point. 
In everyday clinical practice, dentists and perio-
dontists should be aware that rare systemic 
diseases such as LCH might lead to manifesta-
tions in the oral cavity as the first clinical sign. 
Patients would benefit of a correct multidisci-
plinary approach in the identification and clini-
cal management of this rare entity. 
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